Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer | MicrobiomeTrials← Back to trialsNCT03030404
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
CompletedOBSERVATIONAL
Trial Details
Start: 2017-01-27Est. Completion: 2025-03-31
Enrollment target: 733 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Advanced CancerPancreatic Cancer
This is a prospective, single-arm, pilot feasibility clinical trial designed to evaluate the feasibility and safety of a…
Toronto, CanadaEst. completion Jun 1, 2027
Chemotherapy Effect
This study focuses on patients with H. pylori-positive resectable locally advanced adenocarcinoma of the gastric and oes…
Guangzhou, ChinaEst. completion Dec 28, 2026
Phase 3
Completed
Gastro-Oesophageal Cancer
To determine if the regorafenib and nivolumab combination (RegoNivo) improves overall survival compared with current sta…
Scottsdale, United StatesCompleted Jan 14, 2025